- Home
- MKTW vs VNRX Comparison
MKTW vs VNRX Comparison
Compare MKTW & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKTW | VNRX |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 38.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MKTW | VNRX |
|---|---|---|
| Price | $14.99 | $0.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $20.00 | $2.50 |
| AVG Volume (30 Days) | 13.0K | ★ 2.1M |
| Earning Date | 02-27-2026 | 11-13-2025 |
| Dividend Yield | ★ 5.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $342,206,000.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | $5.82 | ★ N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $9.08 | $0.22 |
| 52 Week High | $21.74 | $0.94 |
Technical Indicators
Market Signals| Indicator | MKTW | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 67.56 |
| Support Level | $14.17 | $0.22 |
| Resistance Level | $15.61 | $0.28 |
| Average True Range (ATR) | 0.63 | 0.02 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 40.95 | 81.53 |
Price Performance
Historical ComparisonAbout MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.